logo
Sleeping, eating, or sex? There's a cannabis strain for that

Sleeping, eating, or sex? There's a cannabis strain for that

Boston Globe02-06-2025

Iannuccilli said the days of buying cannabis based on whether it's an
His web-based platform called
Advertisement
On the
Get Rhode Map
A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State.
Enter Email
Sign Up
The platform will also recommend pairings for 'wellness' conditions like stress, appetite, and nausea.
Iannuccilli, a radiologist who previously worked in oncology, spoke to the Globe about the new software, and how he hopes it changes the way people shop for cannabis.
Advertisement
Q: Tell me about your new software PowerLeaf, and why did you feel like it was necessary?
Iannuccilli:
The vast majority of consumers don't understand that cannabis goes well beyond THC. There are other ingredients in the product — in fact, hundreds of them — that vary from strain to strain. And those ingredients actually do play into the differences in mood or the spectrum of effects that consumers get from the product itself.
So the software that we developed takes the individual product that is on the shelf, that is seed-to-sale tracked from the grower, and it takes the lab results that were generated for that product from the regulatory testing. Those lab results get processed by a proprietary algorithm that I built around the science of cannabis, and it actually spits out information that can be used by the consumer to actually understand what the effects are going to be.
What are some of the things that a customer would filter for?
There are about 11 dominant activity states that we've identified. It can be exercise, just general relaxation, some people like to use it for meditation or stretching, and a lot of people are using it for intimacy.
Some of these ingredients, they don't even need to get into your body. They don't need to be absorbed. If they tickle the nerve endings that are in your nose and your brain recognizes an aroma and says, 'oh, this smells like lavender,' not only does your brain recognize that, but it's also starting to release the chemical in your brain that has a calming effect.
So do you not even need to smoke it?
Advertisement
You don't need to smoke it. But in order to get the aromatic effect, you do need to smell it. Inhaling is a very, very common method of using cannabis. As a physician, I am actually trying to do my best to educate consumers not only about what product to pick, but the safest way to consume it. So if you're going to inhale it, you can use other devices like a vaporizer — whether it vaporizes the dry herb or it's an oil form of the product — to create that aroma without actually having to burn the product.
Does this work for edibles? Because that wouldn't have the aroma.
It doesn't work for edibles.
I've seen the app Leafly, or StrainBrain, or dispensaries that let you filter by mood. How is your product different?
We are different because we are not going on subjective consumer reviews of a product experience.
Let's say you strolled into a dispensary here in Rhode Island and you heard a lot about this product, 'Blue Dream.' The 'Blue Dream' that someone had in California who wrote a review on it could be chemically very different than what's being sold to you over here in Rhode Island. This platform doesn't just rely on the name of the product. It actually pulls the chemical ingredients for the exact product that you're looking to buy on the shelf.
A terminal inside Mother Earth Wellness, a dispensary in Pawtucket, allows customers to select an activity and receive a strain recommended by the PowerLeaf software.
Steph Machado/Globe Staff
Can't I just go up to the budtender and say, hey, I'm looking for a strain that's going to help me sleep?
You can, but the level of budtender education really varies in the industry. We're very new. A lot of people are very familiar with cannabis, but they're not so familiar with the science behind it.
Advertisement
In the industry we do see a lot of gamesmanship. And it's not fair to the consumer, but if something is selling and is very popular and there's a trend, people are going to go out and they're going to be looking for it. So it's very easy for a cultivator that isn't so sincere to just change the name of something that they think is similar and say, oh yeah, this is 'Super Orange Soda' or whatever that hip strain is at the time. And consumers really don't have that level of transparency.
Some people will say this is just marketing, you're trying to sell these products. How would you change their minds?
I would say you're absolutely right, but it's based on truth.
This is actually chemistry, it's not just the THC effect. What we're trying to do with this platform is we are trying to get people to understand that they should not be shopping by THC potency. And in fact, when you overwhelm the experience with THC, the nuanced mood effects that a lot of people are looking for get drowned out.
If you're able to scale it, how does this change the industry?
It changes the industry by more effectively pairing the product to the consumer in a meaningful way. Think of wine: it's not just red versus white. Cannabis should be the same way. We're trying to get consumers to see that cannabis is a lot like wine.
This Q&A has been condensed for length and clarity.
The Boston Globe's weekly Ocean State Innovators column features a Q&A with Rhode Island innovators who are starting new businesses and nonprofits, conducting groundbreaking research, and reshaping the state's economy. Send tips and suggestions to reporter Alexa Gagosz at
.
Advertisement
Steph Machado can be reached at

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Can Boston's innovation scene get its mojo back? The Globe's 2025 Tech Power Players say yes.
Can Boston's innovation scene get its mojo back? The Globe's 2025 Tech Power Players say yes.

Boston Globe

time9 hours ago

  • Boston Globe

Can Boston's innovation scene get its mojo back? The Globe's 2025 Tech Power Players say yes.

But the local tech scene has more than a chance to regain its buzz. And the road back to prominence goes through what investors say is the only area in technology that matters right now: artificial intelligence. How — and how quickly — the Boston, however, has an advantage, one captured by the Globe' s Tech Power Players, our annual list of the most consequential leaders in the region's innovation economy. In a word, it's diversity — an exceptional combination of academics, entrepreneurs, investors, and industries, ranging from software to clean energy to health care. Advertisement This diversity provides the talent and opportunity to not only advance foundational AI models that learn from vast troves of data, but also to develop applications that spread the benefits of AI to businesses and consumers — in ways that affect lives. Thanks to key leaders in the scene, that development is underway. Advertisement PathAI, a Boston company that has raised more than $250 million in VC funding, has trained AI models to help pathologists diagnose disease and pharmaceutical companies to develop treatments while improving laboratory workflows; the firm is led by physician-scientist-turned-CEO Andy Beck. Familiar Machines & Magic of Woburn, Boston firm Motional's IONIQ 5 robotaxi parked along the Boston Harbor. Motional The state's biggest industries, meanwhile, are looking to AI — and local tech firms — to make them more efficient, effective, and competitive. Boston Medical Center, for example, is experimenting with AI tools to schedule operating rooms, translate medical records into different languages, and take notes during doctor-patient conversations, allowing doctors to focus on care. 'When you put together health care with all the innovation in Boston,' says Joy Brown, BMC's chief digital information officer, 'you have the opportunity to change health care.' When it comes to emerging technologies, the race often goes to the early, not just the swift. The question is whether Boston, which famously missed the personal computer wave and the interactive, social internet known as Web 2.0 (so long, Facebook!), is embracing AI too late. The Advertisement The Bay Area accounted for 33 of the 50 companies on Mikey Shulman, CEO and cofounder of Suno, in the company's Cambridge office. Barry Chin/Globe Staff 'It's time for Boston to reinvent itself,' says Adrian Mendoza, founder and general partner of the Boston VC firm Mendoza Ventures. 'We've got to create an AI hub here.' Mendoza and others in the tech community say the state should support AI on the scale of the vaunted biotech initiative, which was launched in 2008 and solidified Boston and Cambridge as the premier life sciences cluster. Daniela Rus, director of the Computer Science and Artificial Intelligence Laboratory at MIT, says the key is creating compelling opportunities for local university graduates to stay here rather than take their smarts, ambitions, and startups to Silicon Valley and other places. One way to attract and keep talent here, she says, would be to provide startups low- or no-cost access to the massive — and expensive — computing power needed to build and train AI models. Most important, Rus says, the state needs to go big. 'The moment is now,' she says, 'not 10 years from now.' Rus is among those who say the Advertisement Sabrina Mansur, executive director of the Massachusetts AI Hub, the Healey administration's AI initiative, says the $100 million will be a catalyst to encourage partnerships between companies, industries, universities, and government. Massachusetts, she adds, can offer more than just money to AI entrepreneurs; the state presents the opportunity to work with industries such as robotics, clean energy, and biotech. 'This is where you come to change the world,' Mansur says. Just look at the region's clean energy and sustainability sectors, which have some of the world's leading companies. Form Energy, cofounded by MIT materials scientist A computer rendering of a commercial-scale fusion power plant that Commonwealth Fusion Systems plans to build in Virginia, not far from Washington D.C. Commonwealth Fusion Systems Is all this enough to change the trajectory of the local tech sector? Employment in Boston-area startups declined more than 4 percent last year, according to San Francisco VC firm SignalFire, while venture investment in local information technology companies fell to the lowest level in six years, according to PitchBook. Advertisement But local techsters say the region still has the key ingredients: talent and money. Universities, teaching hospitals, and growing companies continue to fight to attract the best and the brightest while venture capital remains a robust industry. Only California and New York have bigger VC sectors than Massachusetts, according to the National Venture Capital Association. What Boston needs to become a stronger innovation hub are more successful home-grown companies, along the lines of tech stars HubSpot ($32 billion stock market value), Toast ($25 billion market value), and Klaviyo ($10 billion market value), says Jeff Bussgang, cofounder and general partner of the Boston VC firm Flybridge. What it will take are determined founders, smart investors, and, ultimately, the approach of Red Sox slugger Rafael Devers. 'We just gotta keep swinging hard,' says Bussgang, 'and connect on one or two pitches.' Explore the list by sector Rob Gavin can be reached at

‘Growing cluster' of botox-related botulism cases tied to Milton spa, health officials say
‘Growing cluster' of botox-related botulism cases tied to Milton spa, health officials say

Boston Globe

time3 days ago

  • Boston Globe

‘Growing cluster' of botox-related botulism cases tied to Milton spa, health officials say

Rodrigo Beauty did not immediately return a request for comment Saturday night. It appeared the website for booking appointments had been taken down. Related : State health officials previously Use of botulinum toxin — commonly known by the popular brand name Botox — for cosmetic procedures is widely Advertisement Health officials stress that Botox and other cosmetic procedures should only be administered by licensed professionals in accredited medical settings. Botulism results when the botulinum toxin circulates in the blood, causing a variety of paralytic symptoms. Those symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing, and difficulty breathing. Such symptoms are sometimes followed by muscle weaknesses, which can progress over the course of hours or days. Advertisement In November, a Stoughton woman was Material from previous Globe coverage was included in this report. Camilo Fonseca can be reached at

RetinaClear Vision Formula Gains Attention as Non-Prescription Eye Support Option in 2025
RetinaClear Vision Formula Gains Attention as Non-Prescription Eye Support Option in 2025

Yahoo

time3 days ago

  • Yahoo

RetinaClear Vision Formula Gains Attention as Non-Prescription Eye Support Option in 2025

Non-Prescription Vision Supplement RetinaClear Gains Momentum as Consumers Seek Natural Eye Support in 2025 Chicago, June 07, 2025 (GLOBE NEWSWIRE) -- As public interest in alternative vision health options grows, a non-prescription supplement called RetinaClear has entered the spotlight. Designed for adults seeking daily eye support, RetinaClear is marketed as a vision health solution that may help support macular function, retinal response, and overall ocular performance with consistent use. Available exclusively online, RetinaClear is being promoted via its official website, where eligible customers can access various purchasing options and informational videos. The formulation is presented as a natural approach to eye wellness, with the brand suggesting it may assist users looking to protect vision clarity as they age. Although RetinaClear is not a medication and is not intended to diagnose, treat, cure, or prevent any disease, its creators emphasize the importance of taking proactive steps for ocular health. The website explains how poor circulation, oxidative stress, and lifestyle choices can contribute to age-related vision concerns—factors the supplement aims to address through consistent daily use. Consumer interest in vision support supplements has grown significantly in 2025, driven by increasing screen exposure and a desire for proactive wellness strategies. RetinaClear joins a crowded yet competitive marketplace of non-prescription products targeting eye health support. Those interested in learning more or securing a supply of RetinaClear can visit the product's official website: Promotional offers and multi-bottle bundles may be available for first-time buyers. About RetinaClear RetinaClear is a dietary supplement marketed as a natural vision support formula. It is not a prescription drug and should not be used as a substitute for medical advice, diagnosis, or treatment. Individuals are encouraged to consult their healthcare provider before beginning any new supplement regimen. Media Contactsupport@ E 35th Dr #100Aurora, CO 80011 USA(US) 1-302-496-4906(INT) +44-7727-682993 DISCLAIMER: The statements made herein have not been evaluated by the Food and Drug Administration. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease. This release contains affiliate links. As an independent publication, we may receive a commission from qualifying purchases made through the links provided. CONTACT: support@ 19655 E 35th Dr #100 Aurora, CO 80011 USA (US) 1-302-496-4906 (INT) +44-7727-682993

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store